FAT1 c.263A>G ;(p.Y88C)

Variant ID: 4-187630719-T-C

NM_005245.3(FAT1):c.263A>G;(p.Y88C)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery
Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI
Publication Date: 2023-03-02

Variant appearance in text: FAT1: Tyr88Cys
PubMed Link: 36862804
Variant Present in the following documents:
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6
View BVdb publication page



SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas.

Frontiers In Oncology
Fu, Haiying H; Zhou, Huarong H; Qiu, Yanyan Y; Wang, Jianfei J; Ma, Zhiming Z; Li, Hongping H; Zhang, Feng F; Qiu, Chenxi C; Shen, Jianzhen J; Liu, Tingbo T
Publication Date: 2021

Variant appearance in text: FAT1: Y88C
PubMed Link: 34926267
Variant Present in the following documents:
  • Main text
  • fonc-11-765544.pdf
View BVdb publication page



Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.

Nature Communications
Su, Dan D; Zhang, Dadong D; Jin, Jiaoyue J; Ying, Lisha L; Han, Miao M; Chen, Kaiyan K; Li, Bin B; Wu, Junzhou J; Xie, Zhenghua Z; Zhang, Fanrong F; Lin, Yihui Y; Cheng, Guoping G; Li, Jing-Yu JY; Huang, Minran M; Wang, Jinchao J; Wang, Kailai K; Zhang, Jianjun J; Li, Fugen F; Xiong, Lei L; Futreal, Andrew A; Mao, Weimin W
Publication Date: 2019-11-07

Variant appearance in text: FAT1: 263A>G; Y88C
PubMed Link: 31700061
Variant Present in the following documents:
  • 41467_2019_12846_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab.

Journal Of Translational Medicine
Niehr, Franziska F; Weichert, Wilko W; Stenzinger, Albrecht A; Budach, Volker V; Tinhofer, Ingeborg I
Publication Date: 2015-04-01

Variant appearance in text: FAT1: Tyr88Cys
PubMed Link: 25890004
Variant Present in the following documents:
  • Main text
  • 12967_2015_Article_456.pdf
View BVdb publication page



Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

Nature Genetics
Balbás-Martínez, Cristina C; Sagrera, Ana A; Carrillo-de-Santa-Pau, Enrique E; Earl, Julie J; Márquez, Mirari M; Vazquez, Miguel M; Lapi, Eleonora E; Castro-Giner, Francesc F; Beltran, Sergi S; Bayés, Mònica M; Carrato, Alfredo A; Cigudosa, Juan C JC; Domínguez, Orlando O; Gut, Marta M; Herranz, Jesús J; Juanpere, Núria N; Kogevinas, Manolis M; Langa, Xavier X; López-Knowles, Elena E; Lorente, José A JA; Lloreta, Josep J; Pisano, David G DG; Richart, Laia L; Rico, Daniel D; Salgado, Rocío N RN; Tardón, Adonina A; Chanock, Stephen S; Heath, Simon S; Valencia, Alfonso A; Losada, Ana A; Gut, Ivo I; Malats, Núria N; Real, Francisco X FX
Publication Date: 2013-12

Variant appearance in text: FAT1: Y88C
PubMed Link: 24121791
Variant Present in the following documents:
  • NIHMS525200-supplement-2.xls, sheet 1
View BVdb publication page